123 related articles for article (PubMed ID: 7779524)
1. Differential mechanism of retention of Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor: a novel radiopharmaceutical for positron emission tomography imaging.
Fujibayashi Y; Taniuchi H; Wada K; Yonekura Y; Konishi J; Yokoyama A
Ann Nucl Med; 1995 Feb; 9(1):1-5. PubMed ID: 7779524
[TBL] [Abstract][Full Text] [Related]
2. Cytosolic/microsomal redox pathway: a reductive retention mechanism of a PET-oncology tracer, cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (cu-PTSM).
Shibuya K; Fujibayashi Y; Yoshimi E; Sasai K; Hiraoka M; Welch MJ
Ann Nucl Med; 1999 Oct; 13(5):287-92. PubMed ID: 10582796
[TBL] [Abstract][Full Text] [Related]
3. Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM), a metal complex with selective NADH-dependent reduction by complex I in brain mitochondria: a potential radiopharmaceutical for mitochondria-functional imaging with positron emission tomography (PET).
Taniuchi H; Fujibayashi Y; Okazawa H; Yonekura Y; Konishi J; Yokoyama A
Biol Pharm Bull; 1995 Aug; 18(8):1126-9. PubMed ID: 8535408
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria-selective reduction of 62Cu-pyruvaldehyde bis(N4-methylthiosemicarbazone) (62Cu-PTSM) in the murine brain; a novel radiopharmaceutical for brain positron emission tomography (PET) imaging.
Fujibayashi Y; Wada K; Taniuchi H; Yonekura Y; Konishi J; Yokoyama A
Biol Pharm Bull; 1993 Feb; 16(2):146-9. PubMed ID: 8395929
[TBL] [Abstract][Full Text] [Related]
5. Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent cu-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells.
Obata A; Yoshimi E; Waki A; Lewis JS; Oyama N; Welch MJ; Saji H; Yonekura Y; Fujibayashi Y
Ann Nucl Med; 2001 Dec; 15(6):499-504. PubMed ID: 11831397
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a potential generator-produced PET tracer for cerebral perfusion imaging: single-pass cerebral extraction measurements and imaging with radiolabeled Cu-PTSM.
Mathias CJ; Welch MJ; Raichle ME; Mintun MA; Lich LL; McGuire AH; Zinn KR; John EK; Green MA
J Nucl Med; 1990 Mar; 31(3):351-9. PubMed ID: 2308007
[TBL] [Abstract][Full Text] [Related]
7. Subcellular distribution of tissue radiocopper following intravenous administration of 67Cu-labeled Cu-PTSM.
Baerga ID; Maickel RP; Green MA
Int J Rad Appl Instrum B; 1992 Aug; 19(6):697-701. PubMed ID: 1522024
[TBL] [Abstract][Full Text] [Related]
8. Species-dependent binding of copper(II) bis(thiosemicarbazone) radiopharmaceuticals to serum albumin.
Mathias CJ; Bergmann SR; Green MA
J Nucl Med; 1995 Aug; 36(8):1451-5. PubMed ID: 7629593
[TBL] [Abstract][Full Text] [Related]
9. Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET.
Green MA; Klippenstein DL; Tennison JR
J Nucl Med; 1988 Sep; 29(9):1549-57. PubMed ID: 3261785
[TBL] [Abstract][Full Text] [Related]
10. Production and tumour uptake of [64Cu]Pyruvaldehyde-bis (N4-methylthiosemicarbazone) for PET and/or therapeutic purposes.
Jalilian AR; Rowshanfarzad P; Kamrani YY; Shafaii K; Mirzaii M
Nucl Med Rev Cent East Eur; 2007; 10(1):6-11. PubMed ID: 17694494
[TBL] [Abstract][Full Text] [Related]
11. Retention of the radiotracers 64Cu-ATSM and 64Cu-PTSM in human and murine tumors is influenced by MDR1 protein expression.
Liu J; Hajibeigi A; Ren G; Lin M; Siyambalapitiyage W; Liu Z; Simpson E; Parkey RW; Sun X; Oz OK
J Nucl Med; 2009 Aug; 50(8):1332-9. PubMed ID: 19617332
[TBL] [Abstract][Full Text] [Related]
12. Application of the new zinc-62/copper-62 generator: an effective labeling method for 62Cu-PTSM.
Matsumoto K; Fujibayashi Y; Yonekura Y; Wada K; Takemura Y; Konishi J; Yokoyama A
Int J Rad Appl Instrum B; 1992 Jan; 19(1):39-44. PubMed ID: 1577613
[TBL] [Abstract][Full Text] [Related]
13. Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.
Wallhaus TR; Lacy J; Whang J; Green MA; Nickles RJ; Stone CK
J Nucl Med; 1998 Nov; 39(11):1958-64. PubMed ID: 9829589
[TBL] [Abstract][Full Text] [Related]
14. Myocardial kinetics of potassium-38 in humans and comparison with copper-62-PTSM.
Melon PG; Brihaye C; Degueldre C; Guillaume M; Czichosz R; Rigo P; Kulbertus HE; Comar D
J Nucl Med; 1994 Jul; 35(7):1116-22. PubMed ID: 8014667
[TBL] [Abstract][Full Text] [Related]
15. Measurement of regional cerebral blood flow with copper-62-PTSM and a three-compartment model.
Okazawa H; Yonekura Y; Fujibayashi Y; Mukai T; Nishizawa S; Magata Y; Ishizu K; Tamaki N; Konishi J
J Nucl Med; 1996 Jul; 37(7):1089-93. PubMed ID: 8965175
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cell-labeling methods with ¹²⁴I-FIAU and ⁶⁴Cu-PTSM for cell tracking using chronic myelogenous leukemia cells expressing HSV1-tk and firefly luciferase.
Park JJ; Lee TS; Son JJ; Chun KS; Song IH; Park YS; Kim KI; Lee YJ; Kang JH
Cancer Biother Radiopharm; 2012 Dec; 27(10):719-28. PubMed ID: 23009582
[TBL] [Abstract][Full Text] [Related]
17. The effects of glutathione depletion on the biodistribution of Cu(PTSM) in rats.
Barnhart-Bott A; Green MA
Int J Rad Appl Instrum B; 1991; 18(8):865-9. PubMed ID: 1800462
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of copper-PTSM in isolated hearts: a novel tracer for measuring blood flow with positron emission tomography.
Shelton ME; Green MA; Mathias CJ; Welch MJ; Bergmann SR
J Nucl Med; 1989 Nov; 30(11):1843-7. PubMed ID: 2809749
[TBL] [Abstract][Full Text] [Related]
19. Clinical application and quantitative evaluation of generator-produced copper-62-PTSM as a brain perfusion tracer for PET.
Okazawa H; Yonekura Y; Fujibayashi Y; Nishizawa S; Magata Y; Ishizu K; Tanaka F; Tsuchida T; Tamaki N; Konishi J
J Nucl Med; 1994 Dec; 35(12):1910-5. PubMed ID: 7989968
[TBL] [Abstract][Full Text] [Related]
20. Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion.
Green MA; Mathias CJ; Welch MJ; McGuire AH; Perry D; Fernandez-Rubio F; Perlmutter JS; Raichle ME; Bergmann SR
J Nucl Med; 1990 Dec; 31(12):1989-96. PubMed ID: 2266398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
